ARTEMISIA / COVID 19
đżArtemisia /Covid 19đż
Un document est parti pour rĂ©pondre Ă lâappel Ă projet Covid19 de lâArmĂ©e française.
En résumé :
– 85% des chinois malades du Covid19 ont pris un cocktail de plante adaptĂ© Ă leur Ă©tat clinique .
– LâArtemisia annua a Ă©tĂ© donnĂ©e en curatif associĂ© Ă la mĂ©dication conventionnelle choisie dans les cas modĂ©rĂ©s Ă sĂ©vĂšres ( atteintes pulmonaires ) comme pendant lâĂ©pidĂ©mie de SARS .
– La posologie est de 10g/litre par jour en dĂ©coction de 2 min jusquâĂ fin des symptĂŽmes pulmonaires.
– LâArtemisia annua possĂšde 4 molĂ©cules actives in vitro contre le SARS -CoV-2 : lutĂ©oline, kaempferol, quercĂ©tine et apigĂ©nine .
– Aucune efficacitĂ© en prĂ©vention rĂ©pertoriĂ©e ..
Il doit ĂȘtre rĂ©alisĂ©e une Ă©tude clinique de toute urgence !
Sources :
1- w.ijbs.com/v16p1708.htm. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective, Int. J. Biol. Sci. 16, 1708â1717 (2020). Yang, Y., Islam, M. S., Wang, J., Li, Y. Chen, X.
2-WHO Report – SARS: Clinical Trials on Treatment Using a Combination of Traditional Chinese Medicine and Western Medicine
3-ChemRxiv – Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface, UT Battelle, pp. 10-11. Smith M., Jeremy C. Smith (2020)
4- www.mdpi.com/1420-3049/15/5/3135 – Flavonoids from Artemisia annua L. as Antioxidants and Their potential Synergism with Artemisinin against Malaria and Cancer, Molecules 2010, p.5. Ferreira J. F. S., Devanand L. Luthria, Tomikazu Sasaki, Arne Heyerick (2010)
5- Potential Inhibitor of COVID-19 Main Protease (Mpro) Khaerunnisa, S. H. Kurniawan, R. Awaluddin, S. Suhartati , S. Soetjipto, from Several Medicinal Plant Compounds by Molecular Docking Study, pp 6-7 (2020)
6- www.nature.com/articles/s41477-020-0628-0#ref-CR1, « Redeploying plant defences », Nature Plants volume 6, page177 (March 2020)